This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Board Nf Regents the Inivercitvof Texas Cvctom, H. Lee Moffitt Cancer Center and Research Institute, Inc., Iovance Biotherapeutics, Inc.. Active years: 2022-2026.
Company Filing History:
1 out of 1 
1 out of 311 
1 out of 110 
Years Active: 2022-2026
Title: MacLean S Hall: Innovator in Tumor-Infiltrating Lymphocyte Therapy
Introduction
MacLean S Hall is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative methods for expanding tumor-infiltrating lymphocytes for adoptive cell therapy. With a total of 2 patents, Hall's work is paving the way for advancements in cancer therapies.
Latest Patents
One of Hall's latest patents focuses on the enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy. This method involves culturing tumor fragments from the subject in a culture medium containing IL-2 and a 41BB agonist. This approach is effective in expanding tumor-infiltrating lymphocytes with enriched tumor-reactivity and specificity. Additionally, the patent discloses a method for treating tumors in subjects, which includes administering nonmyeloablative lymphodepleting chemotherapy followed by the administration of the expanded tumor-infiltrating lymphocytes.
Career Highlights
Throughout his career, MacLean S Hall has worked with esteemed organizations such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and the Board of Regents of the University of Texas System. His work in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Some of Hall's notable coworkers include Jeffrey S Weber and Jessica Ann Chacon. Their collaborative efforts have contributed to the advancement of cancer treatment methodologies.
Conclusion
MacLean S Hall's innovative approaches in the field of tumor-infiltrating lymphocyte therapy highlight his commitment to improving cancer treatment. His patents and collaborations reflect a dedication to advancing medical science and providing new hope for patients.